Supplementary Methods, Figures 1-6 from Enhanced Efficacy of Therapeutic Cancer Vaccines Produced by Co-Treatment with &lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt; Heparin-Binding Hemagglutinin, a Novel TLR4 Agonist